Pacific Biosciences Of California, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 69,684 | 0.5% | 37,264,228 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 39,583 | 0.2% | 30,924,103 | 9/30/2025 |
| 2025 Q2 | 7/30/2025 | 45,010 | 0.3% | 36,298,163 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 43,045 | 0.4% | 36,478,441 | 3/31/2025 |
| 2024 Q4 | 2/4/2025 | 65,961 | 0.5% | 36,044,362 | 12/31/2024 |
| 2024 Q3 | 10/31/2024 | 56,791 | 0.5% | 33,406,401 | 9/30/2024 |
| 2024 Q2 | 7/26/2024 | 45,501 | 0.4% | 33,212,454 | 6/30/2024 |
| 2024 Q1 | 4/18/2024 | 124,838 | 0.9% | 33,290,137 | 3/31/2024 |
| 2023 Q4 | 1/17/2024 | 338,487 | 2.0% | 34,504,273 | 12/31/2023 |
| 2023 Q3 | 10/18/2023 | 249,017 | 1.9% | 29,822,440 | 9/30/2023 |
| 2023 Q2 | 7/10/2023 | 354,240 | 2.3% | 26,634,620 | 6/30/2023 |
| 2023 Q1 | 4/17/2023 | 321,388 | 2.2% | 27,753,679 | 3/31/2023 |
| 2022 Q4 | 1/24/2023 | 210,158 | 1.8% | 25,691,681 | 12/31/2022 |
| 2022 Q3 | 10/17/2022 | 166,560 | 1.2% | 28,692,494 | 9/30/2022 |
| 2022 Q2 | 7/11/2022 | 157,896 | 0.9% | 28,045,530 | 6/30/2022 |
| 2022 Q1 | 4/19/2022 | 248,062 | 1.0% | 27,259,521 | 3/31/2022 |
| 2021 Q4 | 1/28/2022 | 539,798 | 1.6% | 26,383,103 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 580,575 | 1.4% | 22,723,075 | 9/30/2021 |
| 2021 Q2 | 8/5/2021 | 716,238 | 1.3% | 20,481,486 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 709,543 | 1.4% | 21,301,191 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 739,410 | 2.0% | 28,504,629 | 12/31/2020 |
| 2020 Q3 | 10/30/2020 | 195,868 | 1.2% | 19,844,780 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 28,399 | 0.3% | 8,231,492 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 12,831 | 0.3% | 4,193,059 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 7,758 | 0.2% | 1,509,414 | 12/31/2019 |